Pod Engine
Podcast thumbnail for Expose MASH [Formerly NASH]

Expose MASH [Formerly NASH]

Claim This Podcast

by Novo Nordisk

4.3(13 reviews)
11 episodes
Updated Weekly
Accepts GuestsHas SponsorsLocation 🇺🇸

Podcast Overview

Recent advances in understanding steatotic liver disease have revealed overlapping biological processes that may contribute to non-alcoholic fatty liver disease (NAFLD). Join us in this podcast series where your colleagues will take you on a journey to better understand the cardiometabolic basis for metabolic dysfunction-associated steatohepatitis (MASH), formerly known as non-alcoholic steatohepatitis (NASH), which has long been recognized as “the hepatic manifestation of the metabolic syndrome.” In this series, we will explore MASH, including epidemiology, pathophysiology, comorbidities, patients at risk, and HCP perspectives on the patient journey. This series is tailored specifically for healthcare professionals seeking deeper insights into MASH. Expose MASH [Formerly NASH] is tailored for healthcare professionals seeking to stay at the forefront of liver disease knowledge. This podcast is sponsored by Novo Nordisk and is intended for U.S. clinicians. This podcast is not to be used as medical advice.

Language

🇺🇲

Publishing Since

7/8/2024

Visit WebsiteAppleView on Apple PodcastsRSS Feed

1 verified contact email on file for Expose MASH [Formerly NASH]

Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.

See contact details

Recent Episodes

Episode thumbnail for Overcoming Barriers to MASLD/MASH Screening in Clinical Practice

November 21, 2025

Overcoming Barriers to MASLD/MASH Screening in Clinical Practice

In this episode of Expose MASH [formerly NASH], our experts will discuss some of the major barriers to screening for MASLD/MASH in the primary care and endocrinology settings. They will identify these barriers and misconceptions that contribute to the low rates of MASLD/MASH diagnosis, and provide their perspectives on how we can best overcome these challenges. This episode is brought to you by Novo Nordisk Inc.

Episode thumbnail for Advanced Practice Providers: A Pillar of Patient Care in MASH

November 17, 2025

Advanced Practice Providers: A Pillar of Patient Care in MASH

In this episode of Expose MASH [formerly NASH]—intended for US healthcare professionals only— we discuss the role that advanced practice providers (APPs) play in the screening and identification of patients with MASH (metabolic dysfunction-associated steatohepatitis). We explore their influence on patient care, their role in coordinating care, and discuss how their involvement in the MASH patient journey can impact patient outcomes. This episode is brought to you by Novo Nordisk Inc.

Episode thumbnail for Cardiovascular Disease and the Liver: A Unified Approach for MASH

November 4, 2025

Cardiovascular Disease and the Liver: A Unified Approach for MASH

In this episode of Expose MASH [formerly NASH]—intended for US healthcare professionals only—we break down the connection between liver and heart disease, focusing on how MASH (metabolic dysfunction-associated steatohepatitis) can increase the risk of cardiovascular disease, and how addressing MASH can help by treating risk factors common to heart disease and MASLD can benefit both heart and liver. We explore why patients with MASH face higher mortality rates, often due to cardiovascular complications, and discuss the importance of integrated care between hepatologists and cardiologists. This episode is brought to you by Novo Nordisk Inc.

11 total episodes available

Deep-dive analytics for Expose MASH [Formerly NASH]

Sign up to explore

Frequently asked questions

Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.

What is Expose MASH [Formerly NASH]?

Recent advances in understanding steatotic liver disease have revealed overlapping biological processes that may contribute to non-alcoholic fatty liver disease (NAFLD). Join us in this podcast series where your colleagues will take you on a journey to better understand the cardiometabolic basis for metabolic dysfunction-associated steatohepatitis (MASH), formerly known as non-alcoholic steatohepatitis (NASH), which has long been recognized as “the hepatic manifestation of the metabolic syndrome.” In this series, we will explore MASH, including epidemiology, pathophysiology, comorbidities, patients at risk, and HCP perspectives on the patient journey. This series is tailored specifically for healthcare professionals seeking deeper insights into MASH.

Expose MASH [Formerly NASH] is tailored for healthcare professionals seeking to stay at the forefront of liver disease knowledge. This podcast is sponsored by Novo Nordisk and is intended for U.S. clinicians. This podcast is not to be used as medical advice.

How often does this podcast release new episodes?

This podcast updates weekly.

Where can I listen to this podcast?

This podcast is available on 6 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.

Does this podcast accept guests?

Yes, this podcast regularly features guests.

Legal Disclaimer

Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.

All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.

We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.

While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.

By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.